nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—Naloxone—ESR1—uterine fibroid	0.294	1	CrCbGaD
Buprenorphine—OPRL1—female reproductive system—uterine fibroid	0.0565	0.103	CbGeAlD
Buprenorphine—CYP2C18—uterine cervix—uterine fibroid	0.0429	0.0786	CbGeAlD
Buprenorphine—CYP2C18—mammalian vulva—uterine fibroid	0.0376	0.0687	CbGeAlD
Buprenorphine—CYP2C18—vagina—uterine fibroid	0.0291	0.0532	CbGeAlD
Buprenorphine—OPRK1—female reproductive system—uterine fibroid	0.0279	0.051	CbGeAlD
Buprenorphine—CYP1A2—nipple—uterine fibroid	0.0223	0.0409	CbGeAlD
Buprenorphine—ABCG2—myometrium—uterine fibroid	0.0199	0.0364	CbGeAlD
Buprenorphine—CYP2A6—vagina—uterine fibroid	0.0192	0.0352	CbGeAlD
Buprenorphine—ABCG2—uterine cervix—uterine fibroid	0.0155	0.0283	CbGeAlD
Buprenorphine—ABCG2—decidua—uterine fibroid	0.0148	0.027	CbGeAlD
Buprenorphine—CYP2C8—endometrium—uterine fibroid	0.0144	0.0264	CbGeAlD
Buprenorphine—CYP3A5—uterine cervix—uterine fibroid	0.0144	0.0263	CbGeAlD
Buprenorphine—ABCG2—urethra—uterine fibroid	0.0142	0.026	CbGeAlD
Buprenorphine—ABCG2—endometrium—uterine fibroid	0.014	0.0256	CbGeAlD
Buprenorphine—ABCG2—mammalian vulva—uterine fibroid	0.0136	0.0248	CbGeAlD
Buprenorphine—ABCG2—uterus—uterine fibroid	0.0129	0.0236	CbGeAlD
Buprenorphine—CYP2C19—vagina—uterine fibroid	0.0124	0.0226	CbGeAlD
Buprenorphine—CYP2C8—female reproductive system—uterine fibroid	0.0119	0.0218	CbGeAlD
Buprenorphine—CYP2C8—vagina—uterine fibroid	0.0108	0.0197	CbGeAlD
Buprenorphine—CYP2C9—female reproductive system—uterine fibroid	0.0106	0.0194	CbGeAlD
Buprenorphine—ABCG2—female gonad—uterine fibroid	0.0106	0.0193	CbGeAlD
Buprenorphine—ABCG2—vagina—uterine fibroid	0.0105	0.0192	CbGeAlD
Buprenorphine—ABCB1—myometrium—uterine fibroid	0.00982	0.018	CbGeAlD
Buprenorphine—CYP3A5—female gonad—uterine fibroid	0.0098	0.0179	CbGeAlD
Buprenorphine—CYP3A5—vagina—uterine fibroid	0.00974	0.0178	CbGeAlD
Buprenorphine—CYP3A4—female reproductive system—uterine fibroid	0.00809	0.0148	CbGeAlD
Buprenorphine—CYP2D6—female reproductive system—uterine fibroid	0.00796	0.0146	CbGeAlD
Buprenorphine—ABCB1—uterine cervix—uterine fibroid	0.00764	0.014	CbGeAlD
Buprenorphine—ABCB1—decidua—uterine fibroid	0.00728	0.0133	CbGeAlD
Buprenorphine—CYP2D6—female gonad—uterine fibroid	0.00724	0.0132	CbGeAlD
Buprenorphine—ABCB1—urethra—uterine fibroid	0.00702	0.0128	CbGeAlD
Buprenorphine—ABCB1—endometrium—uterine fibroid	0.00691	0.0126	CbGeAlD
Buprenorphine—ABCB1—mammalian vulva—uterine fibroid	0.00668	0.0122	CbGeAlD
Buprenorphine—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00645	0.0404	CbGpPWpGaD
Buprenorphine—CYP2C18—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00637	0.0399	CbGpPWpGaD
Buprenorphine—ABCB1—uterus—uterine fibroid	0.00637	0.0116	CbGeAlD
Buprenorphine—ABCB1—female reproductive system—uterine fibroid	0.00572	0.0105	CbGeAlD
Buprenorphine—CYP2C18—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00523	0.0328	CbGpPWpGaD
Buprenorphine—ABCB1—female gonad—uterine fibroid	0.00521	0.00953	CbGeAlD
Buprenorphine—ABCB1—vagina—uterine fibroid	0.00518	0.00947	CbGeAlD
Buprenorphine—CYP2C18—FOXA1 transcription factor network—ESR1—uterine fibroid	0.00437	0.0274	CbGpPWpGaD
Buprenorphine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00429	0.0269	CbGpPWpGaD
Buprenorphine—CYP3A7—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00423	0.0265	CbGpPWpGaD
Buprenorphine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00393	0.0246	CbGpPWpGaD
Buprenorphine—CYP2A6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00388	0.0243	CbGpPWpGaD
Buprenorphine—UGT1A9—PPARA activates gene expression—MED12—uterine fibroid	0.00375	0.0235	CbGpPWpGaD
Buprenorphine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.00367	0.023	CbGpPWpGaD
Buprenorphine—CYP3A7—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00348	0.0218	CbGpPWpGaD
Buprenorphine—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00336	0.021	CbGpPWpGaD
Buprenorphine—CYP2A6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00319	0.02	CbGpPWpGaD
Buprenorphine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0031	0.0194	CbGpPWpGaD
Buprenorphine—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00306	0.0192	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—CYP17A1—uterine fibroid	0.00278	0.0174	CbGpPWpGaD
Buprenorphine—CYP2C18—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00274	0.0172	CbGpPWpGaD
Buprenorphine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00269	0.0168	CbGpPWpGaD
Buprenorphine—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00265	0.0166	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00253	0.0159	CbGpPWpGaD
Buprenorphine—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00251	0.0157	CbGpPWpGaD
Buprenorphine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.0024	0.015	CbGpPWpGaD
Buprenorphine—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00237	0.0148	CbGpPWpGaD
Buprenorphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00221	0.0138	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—CYP17A1—uterine fibroid	0.0022	0.0138	CbGpPWpGaD
Buprenorphine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00219	0.0137	CbGpPWpGaD
Buprenorphine—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00218	0.0136	CbGpPWpGaD
Buprenorphine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00218	0.0136	CbGpPWpGaD
Buprenorphine—UGT1A9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00217	0.0136	CbGpPWpGaD
Buprenorphine—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00216	0.0135	CbGpPWpGaD
Buprenorphine—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00194	0.0122	CbGpPWpGaD
Buprenorphine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00187	0.0117	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—CYP17A1—uterine fibroid	0.00185	0.0116	CbGpPWpGaD
Buprenorphine—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00184	0.0115	CbGpPWpGaD
Buprenorphine—CYP3A7—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00182	0.0114	CbGpPWpGaD
Buprenorphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00179	0.0112	CbGpPWpGaD
Buprenorphine—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00177	0.0111	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—CYP17A1—uterine fibroid	0.00169	0.0106	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00151	0.00949	CbGpPWpGaD
Buprenorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00144	0.00903	CbGpPWpGaD
Buprenorphine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00142	0.00891	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.00134	0.00837	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—HPSE2—uterine fibroid	0.00133	0.0083	CbGpPWpGaD
Buprenorphine—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00132	0.00825	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00122	0.00765	CbGpPWpGaD
Buprenorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00117	0.00732	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.00116	0.00725	CbGpPWpGaD
Buprenorphine—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00114	0.00715	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—HPSE2—uterine fibroid	0.00105	0.00656	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.00103	0.00647	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00102	0.00638	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00101	0.00631	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TNRC6B—uterine fibroid	0.000971	0.00608	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PGR—uterine fibroid	0.000961	0.00602	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.00095	0.00595	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.000941	0.0059	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000937	0.00587	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000929	0.00582	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000889	0.00557	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—HPSE2—uterine fibroid	0.000881	0.00552	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000844	0.00528	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—HPSE2—uterine fibroid	0.000808	0.00506	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	0.000804	0.00504	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000793	0.00497	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000637	0.00399	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000621	0.00389	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000612	0.00384	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MED12—uterine fibroid	0.000568	0.00356	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.000552	0.00346	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000531	0.00332	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—ESR1—uterine fibroid	0.000513	0.00321	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HPSE2—uterine fibroid	0.000493	0.00309	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00049	0.00307	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000481	0.00301	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CYP17A1—uterine fibroid	0.000475	0.00298	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000474	0.00297	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.000453	0.00284	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.000449	0.00281	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MED12—uterine fibroid	0.000449	0.00281	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000444	0.00278	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000432	0.00271	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TNRC6B—uterine fibroid	0.000415	0.0026	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PGR—uterine fibroid	0.00041	0.00257	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000396	0.00248	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HPSE2—uterine fibroid	0.000384	0.0024	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MED12—uterine fibroid	0.000381	0.00239	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MED12—uterine fibroid	0.000377	0.00236	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CYP17A1—uterine fibroid	0.000376	0.00235	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000369	0.00231	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000363	0.00228	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000362	0.00226	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PGR—uterine fibroid	0.00036	0.00225	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MED12—uterine fibroid	0.000346	0.00217	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000319	0.002	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CYP17A1—uterine fibroid	0.000316	0.00198	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000309	0.00194	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TNRC6B—uterine fibroid	0.000307	0.00192	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PGR—uterine fibroid	0.000304	0.0019	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000296	0.00186	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CYP17A1—uterine fibroid	0.00029	0.00181	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MED12—uterine fibroid	0.000273	0.00171	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MED12—uterine fibroid	0.000236	0.00148	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CYP17A1—uterine fibroid	0.000228	0.00143	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ESR1—uterine fibroid	0.000219	0.00137	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MED12—uterine fibroid	0.000211	0.00132	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MED12—uterine fibroid	0.000206	0.00129	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CYP17A1—uterine fibroid	0.000198	0.00124	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MED12—uterine fibroid	0.000194	0.00122	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MED12—uterine fibroid	0.000192	0.0012	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ESR1—uterine fibroid	0.000192	0.0012	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CYP17A1—uterine fibroid	0.000177	0.00111	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000172	0.00108	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MED12—uterine fibroid	0.000164	0.00103	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CYP17A1—uterine fibroid	0.000162	0.00102	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ESR1—uterine fibroid	0.000162	0.00102	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CYP17A1—uterine fibroid	0.000161	0.00101	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CYP17A1—uterine fibroid	0.000138	0.000862	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MED12—uterine fibroid	0.000127	0.000795	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CYP17A1—uterine fibroid	0.000106	0.000665	CbGpPWpGaD
